Saint Luke's Lipid and Diabetes Research Center — Kansas City, Missouri

Saint Luke's Lipid and Diabetes Research Center is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Saint Luke's Lipid and Diabetes Research Center has participated in 6 clinical trials.

Therapeutic areas: Cardiovascular Disease, Hypercholesterolemia, Dyslipidemia.

Sponsors: Pfizer, Global Genomics Group, LLC.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Luke's Lipid and Diabetes Research Center?

Saint Luke's Lipid and Diabetes Research Center has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Luke's Lipid and Diabetes Research Center conducted?

Saint Luke's Lipid and Diabetes Research Center has 6 clinical trials on record. Their work covers Cardiovascular Disease, Hypercholesterolemia, Dyslipidemia.

Is Saint Luke's Lipid and Diabetes Research Center accredited by Crixeo Health?

Saint Luke's Lipid and Diabetes Research Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Saint Luke's Lipid and Diabetes Research Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.